Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.5T | 7.7T | 8.4T | 9.0T |
Cost of revenue | 4.9T | 4.3T | 4.6T | 4.5T |
Gross profit | 4.6T | 3.4T | 3.8T | 4.4T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.6T | 2.2T | 2.7T | 2.5T |
Other operating expenses | 787M | 13.4B | 5.8B | 0 |
Operating income | 1.6T | 501.5B | 723.2B | 1.3T |
Non operating interest income | ||||
Income | 2.2B | 2.4B | 3.8B | 9.9B |
Expense | 29.6B | 17.7B | 31.5B | 9.0B |
Other income expense | — | — | — | — |
Pretax income | 1.6T | 486.2B | 695.6B | 1.3T |
Tax provision | 356.4B | 127.2B | 152.6B | 291.3B |
Net income | 1.2T | 359.0B | 543.0B | 1.0T |
Basic EPS | 32 | — | — | — |
Diluted EPS | 32 | — | — | — |
Basic average shares | 38.2B | — | — | — |
Diluted average shares | 38.2B | — | — | — |
EBITDA | 1.7T | 575.2B | 771.5B | 1.4T |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |